Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Short term Debt (2016 - 2018)

Cardiff Oncology (CRDF) has disclosed Short term Debt for 6 consecutive years, with $1.2 million as the latest value for Q1 2018.

  • Quarterly Short term Debt fell 69.67% to $1.2 million in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Mar 2018, down 69.67% year-over-year, with the annual reading at $1.3 million for FY2017, 43.58% down from the prior year.
  • Short term Debt hit $1.2 million in Q1 2018 for Cardiff Oncology, down from $1.3 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $6.1 million in Q2 2016 to a low of $200792.0 in Q1 2014.
  • Historically, Short term Debt has averaged $2.6 million across 5 years, with a median of $2.1 million in 2014.
  • Biggest five-year swings in Short term Debt: skyrocketed 1426.32% in 2015 and later crashed 78.61% in 2016.
  • Year by year, Short term Debt stood at $1.9 million in 2014, then surged by 175.25% to $5.2 million in 2015, then tumbled by 54.84% to $2.4 million in 2016, then tumbled by 43.58% to $1.3 million in 2017, then decreased by 11.76% to $1.2 million in 2018.
  • Business Quant data shows Short term Debt for CRDF at $1.2 million in Q1 2018, $1.3 million in Q4 2017, and $1.5 million in Q3 2017.